Milla Pharmaceuticals (a member of the Alter Pharma Group) is engaged in the development, licensing / acquisition and commercialization of generic prescription drugs for the U.S. market focused on niche injectable and solution products for hospitals and clinics. Our goal is to deliver high quality medicines; via a world-class supply chain, at affordable prices by leveraging global partnerships with FDA-approved manufacturing facilities from around the world.